Skip to main content

Utilization of Obesity Drugs: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
obesity drugs
Description

The goal of this query was to evaluate utilization patterns of obesity drugs in the Sentinel Distributed Database (SDD). This query consists of two reports.

  • Report 1: This report presents data from the main analysis in which the episode gap was decreased. 
  • Report 2: This report presents data from the sensitivity analysis in which the episode gap was increased.

The study period includes data from January 1, 2008 to December 31, 2017. We distributed this request to 17 Sentinel Data Partners on December 21, 2018.

Deliverables (2)
Sentinel Modular Program Report: Utilization of Obesity Drugs: A Descriptive Analysis, Report 1 Sentinel Modular Program Report: Utilization of Obesity Drugs: A Descriptive Analysis, Report 2
Additional Details
FDA Center
CDER
Time Period
January 1, 2008 - December 31, 2017
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Anti-Obesity Medications (Benzophetamine, Bupropion/Naltrexone, Diethylpropion, Liraglutide, Lorcaserin, Orlistat, Phendimetrazine, Phentermine, Phentermine/Topiramate) & Duration of Use and Patient Characteristics